Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,416 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients.
Yasuda K, Kasuga H, Aoyama T, Takahashi H, Toriyama T, Kawade Y, Iwashima S, Yamada S, Kawahara H, Maruyama S, Yuzawa Y, Ishii H, Murohara T, Matsuo S. Yasuda K, et al. Among authors: maruyama s. J Am Soc Nephrol. 2006 Aug;17(8):2322-32. doi: 10.1681/ASN.2005090958. Epub 2006 Jul 12. J Am Soc Nephrol. 2006. PMID: 16837633
Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
Ishii H, Toriyama T, Aoyama T, Takahashi H, Yamada S, Kasuga H, Ichimiya S, Kanashiro M, Mitsuhashi H, Maruyama S, Matsuo S, Naruse K, Matsubara T, Murohara T. Ishii H, et al. Among authors: maruyama s. Clin Ther. 2007 Jan;29(1):110-22. doi: 10.1016/j.clinthera.2007.12.020. Clin Ther. 2007. PMID: 17379051
Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients.
Yamada S, Ishii H, Takahashi H, Aoyama T, Morita Y, Kasuga H, Kimura K, Ito Y, Takahashi R, Toriyama T, Yasuda Y, Hayashi M, Kamiya H, Yuzawa Y, Maruyama S, Matsuo S, Matsubara T, Murohara T. Yamada S, et al. Among authors: maruyama s. Clin J Am Soc Nephrol. 2010 Oct;5(10):1793-8. doi: 10.2215/CJN.00050110. Epub 2010 Jul 1. Clin J Am Soc Nephrol. 2010. PMID: 20595691 Free PMC article.
Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study.
Takahashi H, Ishii H, Aoyama T, Kamoi D, Kasuga H, Ito Y, Yasuda K, Tanaka M, Yoshikawa D, Maruyama S, Matsuo S, Murohara T, Yuzawa Y. Takahashi H, et al. Among authors: maruyama s. Am J Kidney Dis. 2013 Feb;61(2):254-61. doi: 10.1053/j.ajkd.2012.09.007. Epub 2012 Nov 2. Am J Kidney Dis. 2013. PMID: 23122492
Long-term effects of spironolactone in peritoneal dialysis patients.
Ito Y, Mizuno M, Suzuki Y, Tamai H, Hiramatsu T, Ohashi H, Ito I, Kasuga H, Horie M, Maruyama S, Yuzawa Y, Matsubara T, Matsuo S; Nagoya Spiro Study Group. Ito Y, et al. Among authors: maruyama s. J Am Soc Nephrol. 2014 May;25(5):1094-102. doi: 10.1681/ASN.2013030273. Epub 2013 Dec 12. J Am Soc Nephrol. 2014. PMID: 24335969 Free PMC article. Clinical Trial.
2,416 results